3620 results for «2431»
3620 results
TAVI: stroke, cerebral protection and alternative vascular access
18 Nov 2019 – From PCR London Valves 2019
Consult this session to discover the results of various TAVI trials and studies, and learn more about stroke, cerebral embolic protection and alternative vascular access.
TAVI complications and challenging vascular access
18 Nov 2019 – From PCR London Valves 2019
Spotlight - Challenges for the Heart Team I - A new interventional paradigm for aortic valve disease
18 Nov 2019 – From PCR London Valves 2019
Consult this session on aortic valve disease to learn more about the impact of the latest evidence concerning TAVI vs. SAVR on Heart Team discussions and patient choice (clinical and anatomical characteristics, redistribution of resources and training...), and discover how you and your colleagues can apply this information in...
TAVI: predicting the need for permanent pacing
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about how to predict the need for permanent pacemaker implantation after TAVI, thanks to a selection of studies regarding novel anatomic predictors, newer MDCT measurements, and more!
Challenging clinical scenarios in valve interventions - Hosted by Germany, Spain and Singapore
18 Nov 2019 – From PCR London Valves 2019
Consult this session to discover various challenging clinical cases and complications in valve interventions, such as MitraClip for cardiogenic shock, repositionning of a dislodged ALLEGRA transcatheter aortic valve, delayed coronary obstruction, percutaneous closure of a posterior leaflet perforation, and more!
TAVI: clinical outcomes with new devices and delivery systems
18 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI to learn more about the clinical outcomes with new devices and delivery systems, such as the self-expandable Portico valve, the Portico IDE FlexNav delivery system, the SAPIEN 3 Ultra system, and more!
Transcatheter valve intervention in challenging situations
18 Nov 2019 – From PCR London Valves 2019
Consult this session on transcatheter valve intervention with a selection of studies to discover how to manage challenging situations, such as TAVI in cardiogenic shock, TAVR for failed surgical aortic bioprostheses, and more!
TAVI for a patient with severe aortic stenosis and a mechanical mitral prosthesis - Session with LIVE case
18 Nov 2019 – From PCR London Valves 2019
View this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom
Valve for Life @ PCR London Valves 2019
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about the importance of valvular heart disease across countries in Europe, the EAPCI goals for transcatheter heart valve interventions and the actions supported by the Valve for Life initiative.
Transcatheter edge-to-edge repair for secondary mitral regurgitation - Session with LIVE case
19 Nov 2019 – From PCR London Valves 2019
Watch this session with a LIVE demonstration from Clinique Pasteur - Toulouse, France
Mitral and tricuspid transcatheter valves therapies: time to innovate!
Consult this session on mitral and tricuspid transcatheter valves therapies to learn all about the recent innovations and clinical evidences, and discover the Tendyne Clinical Program, a new transcatheter treatment option that eliminates mitral regurgitation.
Transforming patient access and care for valvular heart disease
17 Nov 2019 – From PCR London Valves 2019
Consult this session on valvular heart disease to learn about the current and future patient transcatheter treatment options and the future challenges they bring for the heart teams, and discover the importance of valve design choice for the patient's future.
The Heart Team 2.0 – Where will we be in 2030?
19 Nov 2019 – From PCR London Valves 2019
Consult this session on the Heart Team 2.0 to gain insight into what the future holds for cardiologists, based on clinical evidence, trends in structural heart disease, artificial intelligence, 3D printing, and more!
New perspectives – Treatment of secondary mitral regurgitation in patients with heart failure
18 Nov 2019 – From PCR London Valves 2019
Consult this session on the treatment of secondary mitral regurgitation in patients with heart failure to learn more about how to implant the Carillon Mitral Contour System, and what is the impact of cinching the mitral apparatus on regurgitant volume and left ventricular remodeling.
Improving patient access and clinical outcomes in the treatment of aortic stenosis - The Edwards Benchmark Program
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the current and future constraints on aortic stenosis treatment in Europe, and gain insight into the Edwards Benchmark Program, aiming to optimize patient outcomes, care pathway and efficiency.
What will be relevant for TAVI assessment in 2020?
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about what will be relevant for TAVI assessment in 2020: key imaging requirements before referral to the Heart Team, which patients may need a pacemaker and when it should be implanted, how modern Heart Teams should function, and more!
PCR London Valves Closing Ceremony
19 Nov 2019 – From PCR London Valves 2019
Consult this session to discover PCR London Valves 2019 Closing Ceremony, which gathered over 3000 participants, and learn all about the key moments and what makes this course a wonderful opportunity to enhance your knowledge on transcatheter therapies for valvular heart disease.
Heart Team 2.0 in action: how to manage complex TAVI procedures
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn how to plan a successful TAVI procedure for your patients with challenging anatomy and high-risk clinical characteristics, such as: with a bicuspid aortic valve and associated aortopathy, with severe LVOT calcification, with a high risk of left main coronary occlusion, and more!
TAVI in patients with associated disease of the aorta
19 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI in patients with associated disease of the aorta to discover various challenging clinical cases: transapical revalving in type B aortic dissection, abdominal aortic rupture treatment during TAVI, double TEVAR for aortic aneurysm and type A aortic dissection, and more!
Will PARTNER-3 and Evolut low-risk trials change my practice?
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about PARTNER-3 and Evolut trials, and gain an in-depth understanding of these trials comparing TAVI and SAVR in patients at low surgical risk, while appreciating their limitations and key remaining questions.
